藥師用藥整合服務對病人處方與全人照護服務研究

An Analysis of Medication Complexity and Holistic Medication Reconciliation Service

10.53106/168232812021123104003

劉佳美(Jia-Mei Liu)；張桓瑋(Huan-We Chang)；謝珮盈(Pei-Ying Hsieh)

多重用藥 ； 用藥整合 ； 全人照護 ； holistic care ； medication reconciliation ； polypharmacy

台灣家庭醫學雜誌

31卷4期（2021 / 12 / 01）

269 - 279

繁體中文

目的：多重用藥（polypharmacy）、高齡及藥品處方複雜都是影響病人用藥安全的風險因子，文獻結果顯示用藥整合提供病人生理層面的用藥安全維護，減少多重用藥和處方複雜造成的風險，本研究以某醫院的用藥整合服務紀錄，分析藥師提供的用藥整合服務成效，並探討病人在用藥整合過程中表示的全人照護需求與藥師提供的服務。方法：本研究的資料為某醫院2019年的用藥整合服務紀錄，分析項目包括服務對象資料、用藥品項數目與頻次、醫療資源使用型態與用藥指導項目，並統計用藥整合服務後用藥品項與頻次的變化以及訪談諮詢櫃台藥師，調查病人接受用藥服務後回饋的意見，用藥複雜度以medication regimen complexity index（MRCI）評量。結果：本研究共分析219位病人接受用藥整合服務的紀錄，病人年齡中位數為71.5歲，每人正在用藥科別中位數為2科，MRCI中位數為29分。經過藥師進行整合服務後，有28位病人的用藥數量及用藥複雜度降低，整合服務前每人用藥數目的中位數為15項，整合後用藥數目的中位數降為11.5項，減少的用藥顆數的中位數為30顆；整合前MRCI中位數為35.8分，整合後下降至30.3分。在17件服務紀錄中有紀錄到心理與社會層面的全人照護，其中藥師提供的心理層面照護共9項，社會層面的照護共8項。結論：在本研究中MRCI與醫療資源使用程度有關，高醫療資源使用的病人，MRCI中位數顯著較高，代表用藥較為複雜度，發生遵醫囑性不佳的風險較高。對於高醫療資源使用、使用特殊劑型且同時有多種疾病的病人，需要醫療專業人員的合作，進行用藥的全面評估與整合，減少用藥複雜度，降低重覆用藥與遵醫囑性不佳等情形。

Background: Polypharmacy, aging, and complex medication regimen are risk factors for adverse drug effect. Literature indicates that medication reconciliation helps increase medication safety and reduce the risk of polypharmacy and complex medication. We analyzed medication reconciliation records of our hospital to evaluate the efficacy of the medication reconciliation service offered by our pharmacists based on the holistic needs of the patients and the responses of our pharmacists to the needs. Methods: Medication reconciliation record in 2019 in one hospital was analyzed, including patient profile, number of medication, dosage and frequency of medication, health resource demand and patient education. Changes in medication dosage and frequency were analyzed, and pharmacists were interviewed to obtain patient's feedback about medication reconciliation service. Medication regimen complexity index (MRCI) was used to measure the complexity of the regimen. Results: A total of 219 medication reconciliation records were analyzed, and the median of age of patients was 71.5 years. Patient's medication was prescribed from one or multiple clinics; the median of clinics was 2. The median of MRCI score was 29. Pharmacists had reduced 28 patients' medication number and MRCI score after reconciliation service. For the 28 patients, the median of medication before and after the reconciliation service were 15 and 11.5. With the service, the median of reduced tablets was 30, leading to a drop from 35.8 to 30.3 in the median of MRCI score. Seventeen records showed patients with psychological and social needs, and pharmacists responded by providing 9 patients with psychological support and health care resources and 8 patients with social support and services. Conclusion: MRCI is correlated with the degree of health resource utilization. Patients with a higher demand for health resource tend to report a higher MRCI score and more complex medication regimen. The risk of medication nonadherence is increased with higher medication complexity. For patients consuming greater health resource, using special formulation of medicine, and with multiple comorbidities, health care professionals should perform comprehensive assessment for medication reconciliation to help decrease the risk of polypharmacy and medication nonadherence.

1. 朱育增,吳肖琪,李玉春,賴美淑,譚醒朝(2010)。探討共病測量方法於健保次級資料之應用。台灣公衛誌，29，191-200。
   連結：
2. 洪暐傑,莊佳惠,吳美儀,楊宜青,吳晉祥,林季緯(2015)。家庭醫師全人醫療照護模式應用於居家照護。台灣家醫誌，25，271-278。
   連結：
3. 陳亮宇(2020)。多重用藥評估與整合。臨床醫學月刊，85，143-148。
   連結：
4. 劉力幗,林明憲(2017)。高齡醫學整合門診。臨床醫學月刊，79，13-18。
   連結：
5. Alves-Conceição, V,Rocha, KSS,Silva, FVN,Silva, ROS,Silva, DTd,Lyra, DPd, Jr(2018).Medication regimen complexity measured by MRCI: a systematic review to identify health outcomes.Ann Pharmacother,52,1117-34.
6. Bourgeois, FT,Shannon, MW,Valim, C,Mandl, KD(2010).Adverse drug events in the outpatient setting: an 11-year national analysis.Pharmacoepidemiol Drug Saf,19,901-910.
7. Chan, AHY,Horne, R,Hankins, M,Chisari, C(2020).The Medication Adherence Report Scale: A measurement tool for eliciting patients’reports of nonadherence.Br J Clin Pharmacol,86,1281-1288.
8. Cohen, JL,Mann, DM,Wisnivesky, JP(2009).Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma.Ann Allergy Asthma Immunol,103,325-331.
9. Engel, GL(1977).The need for a new medical model: a challenge for biomedicine.Science,196,129-136.
10. Garfield, S,Clifford, S,Eliasson, L,Barber, N,Willson, A(2011).Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review.BMC Med Res Methodol,11,149.
11. George, J,Phun, YT,Bailey, MJ,Kong, DCM,Stewart, K(2004).Development and validation of the medication regimen complexity index.Ann Pharmacother,38,1369-1376.
12. Johnell, K,Klarin, I(2007).The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.Drug Saf,30,911-918.
13. Lin, CF,Wang, CY,Bai, CH(2011).Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.Drugs Aging,28,219-225.
14. Mansur, N,Weiss, A,Beloosesky, Y(2012).Looking beyond polypharmacy: quantification of medication regimen complexity in the elderly.Am J Geriatr Pharmacother,10,223-229.
15. Negewo, NA,Gibson, PG,Wark, PA,Simpson, JL,McDonald, VM(2017).Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.Int J Chron Obstruct Pulmon Dis,12,2929-2942.
16. Pantuzza, LL,Ceccato, MdGB,Silveira, MR,Junqueira, LMR,Reis, AMM(2017).Association between medication regimen complexity and pharmacotherapy adherence: a systematic review.Eur J Clin Pharmacol,73,1475-1489.
17. StataCorp(2015).StataCorp: Stata Statistical Software: Release College Station, TX: StataCorp LP, 2015..
18. United Nations: World Population Ageing 2019，2020年9月29日，取自https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_worldpopulationageing_report.pdf
19. Wang, YJ,Chiang, SC,Lee, PC(2018).Is excessive polypharmacy a transient or persistent phenomenon? A nationwide cohort study in Taiwan.Front Pharmacol,9,120.
20. 宋文娟,洪錦墩,陳文意(2008)。台灣老年人口醫療利用與多重慢性疾病之分析研究。臺灣老人保健學刊，4，75-87。
21. 李嘉惠,許翔皓,黃麗月,林秋滿,陳偉立,黃璟隆(2016)。藥品整合資訊系統監測門診多重用藥之成效。臺灣臨床藥學雜誌，24，73-82。
22. 林沄萱,劉淑惠,陳清惠(2008)。靈性護理之臨床應用。護理雜誌，55，69-74。
23. 國家發展委員會：高齡化時程。2020年3月6日，取自https://www.ndc.gov.tw/Content_List.aspx?n=695E69E28C6AC7F3.
24. 陳巧欣,史海雯,楊秀琍,黃莉蓉,林慧玲,蘇錦玲(2019)。用藥安全危險因子之文獻回顧。臺灣臨床藥學雜誌，27，91-106。
25. 陳明正,余文瑞,翁林仲,何清幼(2012)。臺灣老年門診病患多重用藥的整合性及持續性照護。北市醫學雜誌，9，21-29。
26. 黃佳真,邱鈺庭,項怡平,張秀玲(2016)。建置門診個別化用藥指導照會服務暨成效分析。臺灣臨床藥學雜誌，24，238-248。
27. 衛生福利部中央健康保險署，107年西醫基層總額專業醫療服務品質報告年報。2020年5月19日，取自https://www.nhi.gov.tw/Content_List.aspx?n=DC16A4CC179371E8&topn=23C660CAACAA159D.
28. 衛生福利部台灣病人安全資訊網：醫院病安目標。2020年3月6日，取自http://www.patientsafety.mohw.gov.tw/Content/zMessagess/contents.aspx?&SiteID=1&MmmID=621273300317401756&MSID=777752343551741053.
29. 衛生福利部統計處，107年全民健康保險統計。2020年3月6日，取自https://dep.mohw.gov.tw/DOS/np-4562-113.html.
30. 鍾慧,楊凱翔,楊瑛碧(2014)。高齡整合性門診藥師介入之成效。北市醫學雜誌，11，129-134。